CELLULAR Aberration Mine(TESSA)

Embed Size (px)

Citation preview

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    1/59

    CELLULARA B E R R A T I O N S

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    2/59

    Rotessa Joyce D. Ong, R.N.

    What are CELLULAR ABERRATIONS?

    A group of disorderscharacterized by

    abnormal cell growthand the

    ability to metastasize withpotential in killing the host.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    3/59

    Rotessa Joyce D. Ong, R.N.

    What is CANCER?

    The term cancer refers to the group ofdiseases in which cells grow and spread

    unrestrained throughout the body.

    Derives from the latin crab which meanscancer

    Synonymous withneoplasm

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    4/59

    Rotessa Joyce D. Ong, R.N.

    Terminologies Commonly Associated

    with Abnormal Cell Growth

    Anaplastic=without shape or differentiation

    Aneuploid= more or less than the normalnumber of chromosomes

    Apoptosis=programmed cell death

    Benign=new, non-malignant cell growth notneeded for normal growth or replacement

    Carcinogenesis=transformation of a normal cellinto a cancer cell

    Doubling time=the amount of time it takes for atumor to double in size by mitotic cell divisions

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    5/59

    Rotessa Joyce D. Ong, R.N.

    Terminologies Commonly Associated

    with Abnormal Cell Growth

    Gene expression=the activation orturning on of a specific gene to theextent that it synthesizes a specificprotein that influences the activity of

    a cell or a group of cells

    Gene suppression=the deactivation orturning off of a specific gene

    Malignant=cancerous, new growth ofcells by invasion that is not needed fornormal development or tissuereplacement

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    6/59

    Rotessa Joyce D. Ong, R.N.

    Terminologies Commonly Associated

    with Abnormal Cell Growth

    Metastasis=invasive growth of cancer cellsfrom the original tumor into distant areas

    Morphology=appearance or shape

    Neoplasia=new cell growth not needed fornormal body growth or replacement ofdead or missing tissue

    Ploidy=the chromosome content of a cell

    Aneuploidy-chromosome content of a cell iseither greater or lesser than the normal cell

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    7/59

    Rotessa Joyce D. Ong, R.N.

    Terminologies Commonly Associated

    with Abnormal Cell Growth

    Oncogene=a developmental gene capable oftransforming a normal cell into a cancer cell

    Primary tumor=a tumor formed in a specific tissueas a result of a carcinogenic agent or event

    Promotion=enhancement of cell division in a cellinitiated by a carcinogen

    Secondary tumor=a tumor formed as a result ofbreaking off from a primary tumor and spreading to

    distant sites

    Suppressor gene=a gene that supresses theexpression of an oncogene

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    8/59

    Rotessa Joyce D. Ong, R.N.

    Cancer Statistics

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    9/59

    Rotessa Joyce D. Ong, R.N.

    Characteristics of Normal & Abnormal

    CellsCharacteristic Normal Cell Embryonic Cell Benign Tumor

    Cell

    Malignant Cell

    Cell Division None or slow Rapid, continuous Continuous,

    inappropriate

    Rapid, continuous

    Appearance Specific

    morphology

    features

    Anaplastic Specific

    morphologic

    features

    Anaplastic

    Nuclear-

    cytoplasmic ratio

    Small Lar ge Small Lar ge

    Differentiated

    functions

    Many None Many Some or none

    Adherence Tight Loose Tight Loose

    Migratory No Yes No Yes

    Growth Well regulated Well regulated Expansion Invasion

    Chromosomes Diploid (euloid) Diploid (euloid) Diploid (euloid) Aneuploid

    Mitotic Index Low High Low High

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    10/59

    Rotessa Joyce D. Ong, R.N.

    Classification of

    Neoplasms Benign Neoplasia Generally not life-threatening unless

    they occur in a restricted area

    Classified according to tissue

    involvement:

    Glandular tissue (adenoma)

    Bone (osteoma)

    Nerve cells (neuroma)

    Fibrous tissue (fibroma)

    Growth remains circumscribed

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    11/59

    Rotessa Joyce D. Ong, R.N.

    MalignantNeoplasia

    Cells infiltrate surrounding tissue

    Cells produce secondary lesions

    May spread (metastasize) by direct extension, lymphatic permeation,embolization, and diffusion of cancer cells by mechanical means

    Tumors are classified according to the tissue involved

    T

    umors are also classified by a universal system of staging classification (T

    NMsystem) T=primary tumor N=lymph node involvement

    M=designates metastasis

    A number (0-4) after any of these letters designates the degree of involvement

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    12/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    13/59

    Rotessa Joyce D. Ong, R.N.

    BENIGN TUMOR

    MALIGNANT TUMOR

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    14/59

    Rotessa Joyce D. Ong, R.N.

    Classification ofTumors by Tissue of Origin

    Prefix Tissue of Origin Benign Tumor Malignant Tumor

    Adeno Epithelial glands Adenoma Adenocarcinoma

    Chondro Cartilage Chondroma Chondrosarcoma

    Fibro Fibrous connective Fibroma Fibrosarcoma

    Glio Glial cells (brain) Glioma Glioblastoma

    Hemangio Blood vessel Hemangioma Hemangiosarcoma

    Hepato Liver Hepatoma Hepatocarcinoma

    Leiomyo Smooth muscle Leiomyoma Leiomyosarcoma

    Lipo Fat/adipose Lipoma Liposarcoma

    Lympho Lymphoid tissues Hodgkins lymphomaNon-Hodgkins lymphomaBurkitts lymphoma

    Melano Pigment-producing skin Meningioma Melanoma

    Meningio Meninges MeningiomaMeningioblastoma

    Neuro Nerve tissue Neurofibroma NeurosarcomaNeuroblastoma

    Osteo Bone Osteoma Osteosarcoma

    Rhabdo Skeletal muscle Rhabdomyoma Rhabdomyosarcoma

    Squamous Epithelial layer of skin, mucousmembranes, and organ linings Papilloma Squamous cell carcinoma of skin,bladder, lungs, cervix

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    15/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    16/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    17/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    18/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    19/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    20/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    21/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    22/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    23/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    24/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    25/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    26/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    27/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    28/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    29/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    30/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    31/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    32/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    33/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    34/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    35/59

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    36/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    37/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    38/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    39/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    40/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    41/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    42/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    43/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    44/59

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    45/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    46/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    47/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    48/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    49/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    50/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    51/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    52/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    53/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    54/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    55/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    56/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    57/59

    Title

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    58/59

    Rotessa Joyce D. Ong, R.N.

  • 8/6/2019 CELLULAR Aberration Mine(TESSA)

    59/59